You are here
L2 DIAGNOSTICS LLC
UEI: GKA7VH5LFR25
# of Employees: 15
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
A Lyme disease vaccine using newly identified in-vivo expressed antigens
Amount: $595,406.00DESCRIPTION (provided by applicant): Lyme disease is the most common arthropod-borne disease in the United States, with over 38,000 confirmed and probable cases reported in 2009. The causative agent o ...
SBIRPhase I2013Department of Health and Human Services National Institutes of Health -
Therapeutic Inhibition of MIF in Rheumatoid Arthritis
Amount: $988,799.00DESCRIPTION (provided by applicant): The long-term product goal of this project is a small molecule therapeutic to treat rheumatoid arthritis (RA), which acts by reducing the inflammatory response tri ...
SBIRPhase II2012Department of Health and Human Services National Institutes of Health -
Measurement of Beta Cell Death in Diabetes
Amount: $284,931.00DESCRIPTION (provided by applicant): All forms of diabetes are characterized by the death of insulin producing cells. In Type 1 diabetes (T1D), this leads to the reliance on exogenous insulin for su ...
STTRPhase I2012Department of Health and Human Services National Institutes of Health -
Small Molecule Antiviral Agents Against Flaviviruses
Amount: $149,404.00Flaviviruses enter mammalian cells by a mechanism involving a structural rearrangement of the stem region of their envelope protein. The stem region establishes specific molecular contacts with amino ...
SBIRPhase I2012Department of Defense Army -
Diagnostic Assays for early Lyme Borreliosis using in-vivo expressed antigens
Amount: $290,340.00DESCRIPTION (provided by applicant): Lyme disease, due to infection with the Ixodes tick-transmitted spirochete Borrelia burgdorferi, is the most common vector-borne disease in the United States, with ...
SBIRPhase I2012Department of Health and Human Services National Institutes of Health -
Triplex-mediated DNA repair as a novel therapy for Hurler Syndrome patients
Amount: $268,211.00DESCRIPTION (provided by applicant): This is a proposal to test the feasibility of using triplex molecules for use as a therapeutic to correct Hurler Syndrome (HS). Lysosomal storage diseases (LSDs), ...
SBIRPhase I2012Department of Health and Human Services National Institutes of Health -
A nanoparticle-based vaccine against leishmaniasis
Amount: $599,977.00DESCRIPTION (provided by applicant): We propose to develop a recombinant subunit vaccine against cutaneous leishmaniasis. This vaccine will incorporate two protein antigens, TSA/TryP and P-4. Both ant ...
STTRPhase I2011Department of Health and Human Services National Institutes of Health -
T cell cytokine assay for the diagnosis of disseminated Lyme borreliosis
Amount: $281,029.00DESCRIPTION (provided by applicant): Lyme disease, due to infection with the Ixodes tick-transmitted spirochete Borrelia burgdorferi, is the most common vector-borne disease in the United States, with ...
STTRPhase I2011Department of Health and Human Services National Institutes of Health -
Diagnostic tools to link Bacteroides fragilis toxin isotypes and human disease
Amount: $573,352.00DESCRIPTION (provided by applicant): The goal of the proposed research is to develop a series of diagnostic assays that will detect specific types of enterotoxigenic Bacteroides fragilis (ETBF). ETBF ...
SBIRPhase I2011Department of Health and Human Services National Institutes of Health -
Bio-monitoring Methylene Diphenyl Diisocyanate (MDI) exposure and body burden
Amount: $1,356,039.00DESCRIPTION (provided by applicant): Exposure to isocyanate, the essential cross-linker for making polyurethane, is a leading cause of occupational asthma world-wide. Three major types of isocyanate a ...
STTRPhase II2011Department of Health and Human Services National Institutes of Health
